Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Dec 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2038081000001115 | Landiolol hydrochloride | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2053431000001117 | Landiolol hydrochloride (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Landiolol hydrochloride | Is a | Substance with beta adrenergic receptor antagonist mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Landiolol 300mg powder for solution for infusion vials | Has specific active ingredient | True | Landiolol hydrochloride | Inferred relationship | Existential restriction modifier | |
| Rapibloc 300mg powder for solution for infusion vials (AOP Orphan Ltd) | Has specific active ingredient | True | Landiolol hydrochloride | Inferred relationship | Existential restriction modifier | |
| Rapibloc 300mg powder for solution for infusion vials (AOP Orphan Ltd) 1 vial | Has specific active ingredient | True | Landiolol hydrochloride | Inferred relationship | Existential restriction modifier | |
| Landiolol 300mg powder for solution for infusion vials 1 vial | Has specific active ingredient | True | Landiolol hydrochloride | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR